article thumbnail

Research Underscores the Critical Role of Pharmacists in Managing Stiff Person Syndrome

Pharmacy Times

The treatment of SPS focuses mainly on symptom management, such as myalgias, and reducing the immune system’s hyperactivity. High-dose intravenous immune globulin for stiff-person syndrome. 6 Benzodiazepines have GABA-enhancing properties that can target impaired inhibitory neurotransmitters, which are lacking in SPS. Pract Neurol.

article thumbnail

Pharmacist’s Role Expands in the Era of Cannabis Rescheduling

Drug Topics

First, a pharmaceutical company could submit an investigational new drug (IND) application for a product with fixed concentrations of cannabinoids to the FDA for approval. First, what types of cannabis will be available to patients? Secondly, how and where will the natural cannabis products be available? There are 2 likely tracks.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Pharmacists Reimagine Myeloma Care With Insights from ASCO

Pharmacy Times

This is progressing through a phase 3 trial and includes comparator arms with standard-of-care treatments like daratumumab, bortezomib (Velcade; Millennium/Takeda and Janssen Pharmaceutical Companies), and lenalidomide. 2 We’re still trying to figure out where these new treatments best fit.

article thumbnail

FDA Mandates Safety Alterations to Opioid Pain Medication Labels

PharmExec

August 1st 2025 Navigating Distrust: Pharma in the Age of Social Media Miranda Schmalfuhs Ian Baer, Founder and CEO of Sooth, discusses how the growing distrust in social media will impact industry marketing strategies and the relationships between pharmaceutical companies and the patients they aim to serve.

article thumbnail

Understanding Recent Changes to 505(b)(2) Drugs and Reimbursement

Pharmacy Times

In 2022, based upon a complaint filed by a pharmaceutical company, CMS was asked to reevaluate the SSA section that establishes the J-code,” Soefje said. So, the pharmaceutical companies then pushed to get their 505(b)(2) drugs declared sole source,” Soefje said. “If This went into effect in January 2022.”

FDA
article thumbnail

Sanofi to Begin Globally Shipping Beyfortus Ahead of RSV Season

Pharmaceutical Commerce

Backed by more than 40 real-world studies involving 250,000 immunized infants, Beyfortus has consistently proven itself as an effective RSV immunization,” said Thomas Triomphe, Sanofi’se xecutive vice president of vaccines.“To “Our third year of providing RSV protection marks a transformative era in infant health. May 25, 2025.

article thumbnail

Asian Pharma Stocks Dropping As US Cuts Drug Prices

Pharma Marketing Network

According to a recent analysis on Pharma Marketing Network , portfolio managers are advising caution in the Asia-Pacific pharmaceutical sector until regulatory clarity and new pricing structures stabilize. Though these companies operate on longer timelines and more complex supply chains, they arent immune. Is the U.S.